Novel polymorphic forms of an antidiabetic agent: process...

Details Novel polymorphic forms of an antidiabetic agent: process... Novel polymorphic forms of an antidiabetic agent: process...

C - Chemistry, Metallurgy

07

D

C07D 265/38 (2006.01) A61K 31/535 (2006.01) A61K 31/538 (2006.01)

Patent

CA 2370401

This invention relates to novel polymorphic/pseudopolymorphic forms of arginine salt of 3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid, having formula (I). The invention also relates to a pharmaceutical composition comprising the novel polymorphic form or their mixture and a pharmaceutically acceptable carrier. The polymorphic forms of the present invention are more active, as antidiabetic and hypolipidemic agent, than the novel 3-[4-[2-(phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic acid.

L'invention concerne de nouvelles formes polymorphes/pseudompolymorphes d'un sel arginine d'acide 3-[4-[2-(phénoxazine-10-yl)éthoxy]phényl]-2-éthoxypropanoïque de formule (I). L'invention concerne aussi une composition pharmaceutique comprenant les nouvelles formes polymorphes ou leur mélange et un support pharmaceutiquement acceptable. Les formes polymorphes sont plus actives comme agent antidiabétique et hypolipidémique que le nouvel acide 3-[4-[2-(phénoxazin-10-yl)éthoxy]phényl]-2-éthoxypropanoïque.

Affiliated with

Also associated with

Rating

Novel polymorphic forms of an antidiabetic agent: process... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Novel polymorphic forms of an antidiabetic agent: process..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Novel polymorphic forms of an antidiabetic agent: process... will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFCA-PAI-O-1528860